AML (ACUTE MYELOGENOUS LEUKEMIA)
Clinical trials for AML (ACUTE MYELOGENOUS LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new AML (ACUTE MYELOGENOUS LEUKEMIA) trials appear
Sign up with your email to follow new studies for AML (ACUTE MYELOGENOUS LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to stop leukemia from coming back
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding venetoclax to standard chemotherapy can better prevent acute myeloid leukemia (AML) from returning after initial remission. About 232 adults aged 18–65 who are in remission will receive either the standard chemo or the combo. The main goal is to se…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
Fitness check could guide better AML care for seniors
Knowledge-focused OngoingThis study looks back at medical records of 725 older adults (65+) with acute myeloid leukemia (AML). Researchers want to see if matching treatment intensity to a patient's 'fitness' level improves survival. The goal is to learn whether these fitness criteria help doctors choose …
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
CAR-T patients monitored for years in new safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows people who previously received an experimental CAR-T cell therapy from AvenCell for cancers like lymphoma, leukemia, or prostate cancer. The goal is to track long-term side effects, including new cancers, nerve problems, or immune disorders. About 178 participa…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Sponsor: AvenCell Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC